ST. PAUL, Minn.--(BUSINESS WIRE)--St. Jude Medical, Inc. (NYSE:STJ) today announced U.S. Food and Drug Administration (FDA) clearance and European CE Mark approval for the Engage™ and Engage TR™ Introducers. Introducers are the starting point of cardiac catheterization for diagnostic and interventional procedures, helping physicians to safely gain and maintain vascular access.
